A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular wellness peptides.
<iframe src="https://statesidedaily.com/embed/cluster/5d27547f82ed66a5650f1b707bd9aa4e639b44c3" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Peptides get their regulatory closeup"></iframe>
A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular wellness peptides.